Date published: 2026-5-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

TFIIH p62 Inhibitors

TFIIH p62 inhibitors are a specific class of chemical compounds that target the p62 subunit of the TFIIH complex. TFIIH, or Transcription Factor II Human, is a multi-subunit protein complex essential for both transcription initiation by RNA polymerase II and nucleotide excision repair (NER) of damaged DNA. The p62 subunit plays a crucial role in the assembly and stability of the TFIIH complex, interacting with other core components such as XPB, XPD, and p44. By inhibiting the p62 subunit, these compounds can disrupt the integrity and function of the entire TFIIH complex, leading to a decrease in transcriptional activity and impaired DNA repair capabilities. This inhibition is significant because TFIIH is involved in both basal transcription and the cellular response to DNA damage, making it a vital target for understanding the molecular mechanisms underpinning cellular homeostasis and the maintenance of genomic stability.

The chemical structure of TFIIH p62 inhibitors is diverse, but they generally contain functional groups capable of interacting with the key amino acids of the p62 subunit, thus interfering with its binding to other TFIIH components. These interactions are often achieved through hydrogen bonding, hydrophobic interactions, and, in some cases, covalent bonding. Structural studies have shown that the binding of these inhibitors to p62 can induce conformational changes that destabilize the TFIIH complex, further enhancing their inhibitory effects. Researchers use various biochemical and biophysical techniques, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, to elucidate the precise binding modes and structural conformations of these inhibitors. Understanding the detailed mechanisms of action and structural characteristics of TFIIH p62 inhibitors contributes to broader research into cellular transcription regulation and DNA repair processes, offering insights into fundamental biological processes and the cellular response to genomic insults.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

A diterpene triepoxide that inhibits the TFIIH complex, potentially affecting the function of the p62 subunit.

Spironolactone

52-01-7sc-204294
50 mg
$109.00
3
(1)

A diuretic that has been shown to disrupt TFIIH-mediated transcription, indirectly affecting p62.

(+)-Etomoxir sodium salt

828934-41-4sc-215009
sc-215009A
5 mg
25 mg
$151.00
$506.00
3
(2)

An inhibitor of carnitine palmitoyltransferase-1 that has been shown to disrupt TFIIH-mediated transcription, possibly affecting p62.

Dabrafenib

1195765-45-7sc-364477
sc-364477A
sc-364477B
sc-364477C
sc-364477D
5 mg
25 mg
50 mg
100 mg
10 g
$141.00
$260.00
$278.00
$411.00
$12485.00
6
(1)

A BRAF inhibitor known to interact with components of the TFIIH complex, potentially affecting p62.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$117.00
$423.00
11
(1)

Another BRAF inhibitor that may indirectly influence TFIIH and p62 through its effect on transcription and DNA repair pathways.

Cobimetinib

934660-93-2sc-507421
5 mg
$270.00
(0)

A MEK inhibitor that could indirectly affect TFIIH and p62 through modulation of signaling pathways.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

A MEK inhibitor with potential indirect effects on TFIIH and p62 by altering downstream signaling pathways.

Ulixertinib

869886-67-9sc-507296
10 mg
$176.00
(0)

A potent and selective ERK1/2 inhibitor, potentially influencing TFIIH and p62 indirectly.

SCH772984

942183-80-4sc-473205
5 mg
$370.00
5
(0)

Another ERK inhibitor, which could indirectly modulate the function of TFIIH and p62.

MEK 162

606143-89-9sc-488879
10 mg
$306.00
(0)

A MEK inhibitor that may have indirect effects on TFIIH and the p62 subunit through its impact on cellular signaling.